Ecstacy-induced delayed rhabdomyolysis and neuroleptic malignant syndrome in a patient with a novel variant in the ryanodine receptor type 1 gene

22Citations
Citations of this article
35Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We present the case of a 20-year-old woman who developed rhabdomyolysis, disseminated intravascular coagulopathy and multi-organ failure induced by ecstasy. Following initial improvement, she developed delayed rhabdomyolysis then haloperidol-induced neuroleptic malignant syndrome, which was treated with a total of 50 mg.kg -1 dantrolene. Subsequent genetic testing revealed a novel potentially pathogenic variant in the ryanodine receptor type 1 gene. However, caffeine-halothane contracture testing of the patient's mother who carried the same gene variant was negative for malignant hyperthermia. © Anaesthesia © 2012 The Association of Anaesthetists of Great Britain and Ireland.

Cite

CITATION STYLE

APA

Russell, T., Riazi, S., Kraeva, N., Steel, A. C., & Hawryluck, L. A. (2012). Ecstacy-induced delayed rhabdomyolysis and neuroleptic malignant syndrome in a patient with a novel variant in the ryanodine receptor type 1 gene. Anaesthesia, 67(9), 1021–1024. https://doi.org/10.1111/j.1365-2044.2012.07226.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free